Regent Investment Management LLC Poseida Therapeutics, Inc. Transaction History

Regent Investment Management LLC

  • $373 Million
  • Q4 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022
SELL
$1.87 - $5.0 $39,124 - $104,610
-20,922 Closed
0 $0
Q1 2022

Apr 19, 2022
SELL
$3.22 - $7.04 $13,131 - $28,709
-4,078 Reduced 16.31%
20,922 $94,000
Q2 2021

Jul 16, 2021
BUY
$7.96 - $10.07 $15,920 - $20,140
2,000 Added 8.7%
25,000 $251,000
Q1 2021

Apr 20, 2021
BUY
$8.51 - $11.91 $25,530 - $35,730
3,000 Added 15.0%
23,000 $220,000
Q4 2020

Jan 27, 2021
BUY
$8.29 - $11.7 $165,799 - $234,000
20,000 New
20,000 $219,000

Others Institutions Holding PSTX

# of Institutions
97
Shares Held
38.5M
Call Options Held
377K
Put Options Held
22.2K
View Full List

About Poseida Therapeutics, Inc.

PSTX Quotes by TradingView
  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $275M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Regent Investment Management LLC Portfolio

Follow Regent Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email